Search

Search Constraints

You searched for: Author/Creator Stathis, Anastasios

Search Results

21. Preclinical evaluation of the BET bromodomain inhibitor BAY 1238097 for the treatment of lymphoma. (27th June 2017)

22. Prognostic impact of monocyte count at presentation in mantle cell lymphoma. (29th June 2013)

24. Risk factors of central nervous system relapse in mantle cell lymphoma. Issue 9 (September 2013)

25. Single and combined BTK and PI3Kδ inhibition with acalabrutinib and ACP‐319 in pre‐clinical models of aggressive lymphomas. (29th July 2019)

27. The novel atypical retinoid ST5589 down‐regulates Aurora Kinase A and has anti‐tumour activity in lymphoma pre‐clinical models. (3rd August 2015)

30. Zandelisib with continuous or intermittent dosing as monotherapy or in combination with rituximab in patients with relapsed or refractory B-cell malignancy: a multicentre, first-in-patient, dose-escalation and dose-expansion, phase 1b trial. Issue 8 (August 2022)